
Psilocybin Smoking Cessation: What the Research Shows
Psilocybin smoking cessation research from Johns Hopkins has produced abstinence rates well above those seen with nicotine patches or standard medications, with a 2014 pilot showing...

The Best Psychedelic for Addiction? Comparing Ibogaine, Psilocybin, Ketamine, Ayahuasca
There is no single best psychedelic for addiction, because the evidence is organized by which substance you are trying to stop. Psilocybin has the strongest controlled-trial...

Addiction Psychedelic Therapy: What the Science Says About Breaking the Cycle
Early clinical research on addiction and psychedelic therapy is genuinely promising, with controlled trials showing meaningful reductions in heavy drinking and high abstinence rates in tobacco...

Ibogaine for Opioid Addiction: What the Evidence and the Risks Actually Show
Ibogaine opioid addiction treatment can interrupt physical withdrawal and reduce cravings after a single session, an effect no approved medication produces. The evidence comes almost entirely...

Ayahuasca Addiction Treatment: What the Evidence Shows
Research on ayahuasca addiction treatment is both encouraging and genuinely limited. Observational studies and large international surveys report reduced alcohol, tobacco, and cocaine use following ceremonial...

Ibogaine Therapy: A Complete Guide to the Most Powerful and Risky Psychedelic
Ibogaine is a plant-derived psychedelic with real promise for interrupting opioid addiction and, more recently, for treating trauma, but it carries a risk of fatal heart...

LSD Alcoholism Treatment: The Forgotten Research That Started Psychedelic Therapy
Six randomized controlled trials of LSD alcoholism treatment conducted between the 1950s and 1970s, pooled in a 2012 meta-analysis of 536 participants, found that a single...

Ketamine Addiction Treatment: An Emerging Pathway for Alcoholism and Substance Use
Ketamine addiction treatment is supported by several small randomized trials showing improved abstinence in alcohol and cocaine use disorder, but only when the infusion is paired...

Psilocybin Therapy Guide: A Complete Guide to Therapeutic Use
Psilocybin is the active compound in certain mushrooms, and in a therapeutic setting it is used in one or two carefully prepared sessions alongside professional psychological...

Ibogaine Opioid Treatment Research: What 2025-2026 Studies Found
Ibogaine opioid treatment research has moved significantly forward in 2025 and 2026, with new clinical data, a landmark $50 million Texas state investment, and a federal...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.